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Abstract 
Background. Establishing trends of drug overdoses requires 
the identification of individual drugs in death certificates, not 
supported by coding with the International Classification of 
Diseases. However, identifying drug mentions from the literal 
portion of death certificates remains challenging due to the 
variability of drug names. Objectives. To automatically identify 
individual drugs in death certificates. Methods. We use 
RxNorm to collect variants for drug names (generic names, 
synonyms, brand names) and we algorithmically generate 
common misspellings. We use this automatically compiled list 
to identify drug mentions from 703,106 death certificates and 
compare the performance of our automated approach to that of 
a manually curated list of drug names. Results. Our automated 
approach shows a slight loss in recall (4.3%) compared to the 
manual approach (for individual drugs), due in part to 
acronyms. Conclusions. Maintenance of a manually curated 
list of drugs is not sustainable and our approach offers a viable 
alternative. 
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Introduction 
Recent mortality trends show a substantial increase in drug 
overdose death rates in the United States. From 2010 to 2015, 
the rate of drug overdose death has increased from 12.3 to 16.3 
per 100,000 in the U.S. population [1]. Researchers have 
devoted a significant amount of effort to describing drug 
overdose trends and to identifying the population at risk, as 
attempts to address this public health crisis [1–3]. 
Mortality data are a valuable source of information for 
establishing drug overdose trends. Causes of death are 
classified in accordance with the International Classification of 
Disease, Tenth Revision (ICD-10). ICD-10 codes X40-X49 
identify unintentional drug poisoning or overdose deaths, while 
drug-specific overdose deaths are identified by the contributory 
causes of death indicated by “T” codes (e.g., T40.1 indicates 
death due to poisoning by, adverse effect of and underdosing of 
heroin). ICD-10 codes have been used to facilitate the drug 
overdose trends analysis [4–6]. 
While ICD-10 codes support consistent coding of the 
underlying causes of death, they do not provide enough 
granularity especially when it comes to reporting drug overdose 
at the level of individual drugs. While some drugs are assigned 
a unique ICD-10 code, most of them are not. For example, drug 
overdose cases caused by heroin and methadone are assigned 
distinct ICD-10 codes (T40.1 and T40.3 respectively), but drug 
overdose cases caused by fentanyl and tramadol are clustered 
together and assigned the same code (T40.4 - poisoning by 
synthetic narcotics). This issue also affects all the other opioids 
(T40.2), as well as barbiturates (T42.3) and benzodiazepines 
(T42.4). 
To mitigate the granularity issue, researchers have utilized the 
literal portion of death certificates (i.e., a short textual 
description of the cause of death) to identify the contribution of 
a specific drug to drug overdose cases [7]. The death certificates 
in which a specific drug is mentioned can be retrieved and used 
for establishing specific drug overdose trends. Yet, identifying 
drug mentions in death certificates is not a trivial task as drug 
entities are often denoted by different terminology variants, 
including generic names, brand names and synonyms. 
Moreover, drug names are sometimes misspelled in death 
certificates. Therefore, it is important to identify these variants 
in order to have complete and accurate retrieval of death 
certificates in which drugs are mentioned. 
Trinidad et. al. [8] manually inspected death certificates over a 
5-year period (2010-2014) and identified a list of search terms 
for drugs. These search terms were partially populated from 
Substance Abuse and Mental Health Services Administration’s 
(SAMHSA) Drug Abuse Warning Network (DAWN) Drug 
Reference Vocabulary (DRV) and complemented by drug 
mentions identified manually from the literal portion of death 
certificates. These search terms consist of various terminology 
variants, including synonyms, abbreviations, brand names, and 
misspellings. A study team trained in pharmacy and pharmaco-
epidemiology then organized these search terms into their 
corresponding drug entities (around a “principal variant”), as 
illustrated in Figure 1. We refer to this list as the Manually 
Curated List (MCL). 
This list covers a large number of drugs involved in the death 
of decedents but requires a significant amount of manual effort 
from domain experts for its curation. Manual curation is time-
consuming and does not constitute a scalable and sustainable 
approach as new drugs are marketed and new variants appear 
in death certificates. Moreover, while terminology variants for 
a given drug entity were grouped together, the type of variant 
(e.g., brand name, misspelling) was not documented, making it 
impossible to study the specific contribution of each type of 
terminology variant. 
The objective of this study is to explore an automated approach 
to generating a list of search terms for drugs to support the 
identification of individual drugs in death certificates. We 
assess the performance of our Automatically Compiled List 
(ACL) against the Manually Curated List (MCL) for the 
retrieval of death certificates. The main contribution of our 
work is to address the scalability and sustainability of drug 
identification in death certificates, by proposing an automated 
approach to generating the drug list. 
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 Figure 1 –Example of drug entity in the Manually Curated 
List with the “principal variant” (top), and the set of 
terminology variants. 
Methods 
We use RxNorm to collect variants for drug names (generic 
names, synonyms, brand names) and we algorithmically 
generate common misspellings. We use this automatically 
compiled list (ACL) to identify drug mentions from death 
certificates and compare the performance of our automated 
approach to that of the manually curated list (MCL) of drug 
names. (Figure 2). 
 
Figure 2 – Overview of the methods. 
Drug List Compilation 
The first stage focuses on compiling the list of search terms for 
drugs from RxNorm. 
Collecting Drug Names from RxNorm 
RxNorm is a normalized naming system for generic and 
branded drugs from a collection of commonly used public and 
private drug vocabularies [9]. The present study leverages 
RxNorm for populating drug names due to its comprehensive 
coverage of clinical drugs. We collected all names for drug 
entities from the following three RxNorm categories: 
 Ingredients (IN) - a compound or moiety that gives the 
drug its distinctive clinical properties. Ingredients 
generally use the United States Adopted Name 
(USAN), e.g., Fluoxetine. 
 Precise Ingredient (PIN) - a specified form of the 
ingredient that may or may not be clinically active. 
                                                          
1 https://www.wordfrequency.info/free.asp 
Most precise ingredients are salt or isomer forms, e.g., 
Fluoxetine Hydrochloride. 
 Brand Name (BN) - a proprietary name for a family of 
products containing a specific active ingredient, e.g., 
Prozac. 
The rationale for focusing on these three categories is that they 
are sufficient for identifying drug mentions in death certificates. 
While brand names generally correspond to prescription drugs 
(e.g., oxycontin), generic names for ingredients in RxNorm may 
also include substances for which no prescription drugs are 
available (e.g., rofecoxib). Other RxNorm categories, such as 
‘Semantic Clinical Drug’ contain additional information (e.g., 
dose form and strength), usually not mentioned in death 
certificates and not essential for the retrieval of death 
certificates. We collect all synonyms from RxNorm for every 
drug name. 
Eliminating Undesirable Drug Entities 
RxNorm includes drug entities that are not of interest for 
identifying drugs in death certificates and will possibly generate 
false positives in retrieval, e.g., micro-organisms found in 
vaccines or used for allergy testing. We utilized semantic 
categorization (semantic type information) in the Unified 
Medical Language System (UMLS) [10] for filtering 
undesirable drug entities. All drug concepts from RxNorm are 
part of the UMLS Metathesaurus. For the purpose of retrieving 
death certificates, we only consider RxNorm concepts with the 
following UMLS semantic types: 
 T109 - Organic Chemical 
 T116 - Amino acid, peptide or protein 
 T121 - Pharmacologic Substance 
 T126 - Enzyme 
In practice, we search in the UMLS Metathesaurus every 
RxNorm drug concept collected in the previous step and filter 
out those for which the semantic type is not one of the four 
listed above. 
Another practical issue in identifying drug mentions in death 
certificates is that some drugs have brand names that 
correspond to frequently used English terms (e.g., Prevail, 
Thrive, Today). When found in death certificates, these terms 
generally do not denote a drug and will generate false positives 
in retrieval. In practice, we used the list of the top-5000 words 
from Word Frequency Data1 computed from the Corpus of 
Contemporary American English2 to filter out from our drug list 
any brand name that is present in this list. 
Generating Misspellings 
Some drug names are misspelled in death certificates. These 
misspellings indicate the mentions of drug entities but are often 
missed out in retrieval processes. We generated potential 
misspellings using an algorithm inspired by Pimpalkhute et. al. 
[11]. There are two phases in the algorithm: generation phase 
and filtering phase. 
We first generated all variants with an edit distance of 1 (i.e., 
differing from the original by one character through insertion 
[bupropion / buproprion], deletion [fluoxetine / fuoxetine] or 
substitution [Prozac / Prosac]). We did not generate 
misspellings for chemical names (e.g., 1,1,2,2-
tetrafluoroethane) or drug names smaller than 5 characters (e.g. 
2 https://corpus.byu.edu/coca/ 
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Agar, Urea, Tums) to avoid proliferation and ambiguity, 
respectively. 
Misspelling generation has the potential to create a large 
number of variants. Further filtering (phoneme, lexical and 
semantic) is needed to select the most relevant misspellings. 
Phoneme filtering helps to reduce the spelling variants 
generated to a manageable number. Lexical and semantic 
filtering helps to avoid generating ambiguous variants that 
would likely generate false positives in retrieval. 
1. Phoneme filtering helps select misspellings that sound 
like the original term, which are the most likely to be 
found in text. We use the metaphone algorithm to 
identify spelling variants of the original drug name 
with similar pronunciation (see [11] for details). The 
other spelling variants generated in previous steps are 
discarded. 
2. Lexical filtering eliminates existing or potentially 
ambiguous variants. Short variants are discarded 
(variants of 4 characters or less) because short words 
tend to be ambiguous. Variants that correspond to 
existing English words are discarded because their 
mention in text most likely denotes an entity other than 
the drug. Finally, variants that correspond to existing 
drug names are discarded, because they are already 
covered by the main drug list. 
3. Semantic filtering eliminates variants that correspond 
to existing biomedical concepts outside the drug 
domain for the same reason we eliminate variants that 
correspond to existing English words. In practice, we 
use the filter developed for eliminating undesirable 
drug entities (see above). 
Automatically Compiled List of Drug Names 
For the purpose of identifying drug mentions in death 
certificates, we organized the Automatically Compiled List 
(ACL) of drug names around RxNorm ingredients (IN). In 
practice, we grouped RxNorm precise ingredients (PIN) and 
brand names (BN), along with their synonyms and spelling 
variants, together with their corresponding ingredient. For 
example, mentions of Prozac (brand name for fluoxetine) and 
fluoxetine hydrochloride (precise ingredient, salt form of 
fluoxetine) are counted as mentions of fluoxetine. However, we 
keep track of the specific type of terminology variant (e.g., 
brand name) for each variant. 
Evaluation 
We use this automatically compiled list to identify drug 
mentions from death certificates and compare the performance 
of our automated approach to that of the manually curated list 
of drug names. We use a corpus of death certificates from 
Washington State. This corpus spans a period of 14 years (from 
the year 2003 until 2016) and comprises a total of 703,106 death 
certificates. After indexing the death certificates with the 
Elasticsearch search engine, we used the automatically 
compiled list (ACL) and the manually curated list (MCL) to 
query the corpus of death certificates and retrieved one set for 
each list. Counts of death certificates are aggregated by 
ingredient (ACL query) or by principal variant (MCL query). 
For the purpose of comparing ACL and MCL, we normalized 
terms from the MCL to RxNorm using the RxNorm API. 
Results 
Drug List Compilation 
Collecting and Filtering Drug Names from RxNorm 
A total of 22,161 drug names are collected from RxNorm. After 
eliminating undesirable drug entities, 21,459 drug names 
remain (11,396 ingredients, 2714 precise ingredients, 5887 
brand names and 1462 synonyms). 
The 702 variants eliminated are described below. 
 UMLS filtering: 689 RxNorm concepts were 
eliminated because their UMLS semantic type was 
outside the drug domain. Examples include Adenine 
(T114 Nucleic acid), Air (T167 Substance), Apple 
Juice (T168 Food), Candida albicans (T004 Fungus) 
and Human poliovirus (T005 Virus). Additionally, 
five obsolete drug names could not be mapped to the 
UMLS and were eliminated. 
 Eight brand names corresponding to frequently used 
English terms (Legend, Prevail, React, RID, Thrive, 
Today, Tomorrow and Triumph). 
Generating Misspellings 
Our algorithm generated a total of 3,255,198 spelling variants, 
but most of them were eliminated during the filtering phase 
(Table 1). A total of 903,831 spellings variants was retained. 
Table 1 - Number of variants eliminated at each step 
Filtering step 
Number of 
variants 
eliminated 
Number of 
remaining 
variants 
Examples of 
variants 
eliminated 
Phoneme 
filtering 2,343,923 911,275 
azciximab, 
prozaw 
Short variant 
filtering 7132 904,143 
born, corhd, 
parox, dylan 
Existing 
English word 
filtering 
242 903,901 captain, watery, concert 
Existing drug 
name filtering 63 903,838 
butabarbital, 
nexavar, 
protamine 
Semantic types 
filtering 7 903,831 
phosphide, 
ostium, ocular 
 
Automatically Compiled List of Drug Names 
The Automatically Compiled List (ACL) of drug names, after 
eliminating undesirable drug entities and generating 
misspellings, comprises 925,290 variants organized around 
11,396 main drug entities. Figure 3 shows the terminology 
variants for the drug entity diphenhydramine. 
Evaluation 
Overall Retrieval of Death Certificates 
A total of 37,215 unique death certificates were retrieved with 
the ACL query and 49,163 with the MCL query. Of these, 
35,822 death certificates were retrieved by both queries, leaving 
1,393 death certificates retrieved only with the ACL query and 
13,341 retrieved only with the MCL query. The total number of 
death certificates retrieved with any query is 50,556, of which 
the ACL query retrieved 73.6% and the MCL query 97.2%. The 
difference in recall between ACL and MCL (23.6%) was 
expected, since MCL contains non-drug substances and drug 
classes, while ACL is restricted to drug names by construction. 
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 Figure 3 –Example of a drug entity from ACL with different 
types of variants. 
Retrieval of Death Certificates for Individual Drugs 
Quantitative evaluation. There are 1654 drug entities present 
in both MCL and ACL. To assess variant generation in ACL, 
we specifically compared the number of death certificates 
retrieved for those drug entities in common between the two 
lists. A total of 35,674 unique death certificates were retrieved 
with the ACL query and 37,278 with the MCL query. Of these, 
35,633 death certificates were retrieved by both queries, leaving 
41 death certificates retrieved only with the ACL query and 
1,645 retrieved only with the MCL query. The total number of 
death certificates retrieved with any query is 37,319, of which 
the ACL query retrieved 95.6% and the MCL query 99.9%. The 
difference in recall between both lists, when restricted to 
individual drugs, is only 4.3% (i.e., much lower than the loss in 
recall observed overall). Given the significant amount of 
manual effort involved in curating MCL, the slight loss in recall 
is indicative of a strong performance for the ACL query. 
Moreover, the fact that the ACL query retrieved 41 death 
certificates not retrieved with the MCL query (for variants 
including alteplace, remicaide, and gentamycin) demonstrates 
the benefit of a systematic, algorithmic approach to collecting 
drug names and spelling variants. 
Qualitative evaluation. To assess whether ACL and MCL 
would identify similar trends in drug-related mortality, we 
compared the top-20 drug entities retrieved by MCL and ACL 
in death certificates. Table 2 shows that both lists essentially 
identify the same top-20 drugs. Among the top-20 drug entities 
in both lists, 19 overlaps. (Cholesterol is inappropriately 
identified as a drug in ACL, but not MCL.) The ranking of these 
drug entities is also identical in both list, except for the 
permutation of Citalopram and Alprazolam, whose frequencies 
are very close. 
Discussion 
Specific Contribution of Variant Types 
Table 3 shows the overall frequency of death certificates 
retrieved by each type of terminology variant from the ACL. 
While ingredient names account for the vast majority of drug 
mentions, brand names and misspellings also contribute to the 
retrieval of death certificates. 
Table 4 presents the top-5 brand names mentioned in death 
certificates. Overall, the usage of brand names constitutes 3.6% 
(1323/37,215) of all drug mentions. One exception is Coumadin 
(926 mentions) , the brand name of Warfarin (788 mentions). 
Table 2 - Top-20 drug entities identified by MCL and ACL. 
MCL ACL 
Drug entity Freq. Drug entity Freq. 
Ethanol 4561 Ethanol 3588 
Methadone 3377 Methadone 3375 
Methamphetamine 2964 Metamphetamine 2946 
Heroin 2456 Heroin 2446 
Cocaine 2171 Cocaine 2166 
Oxycodone 2100 Oxycodone 2093 
Warfarin 1712 Warfarin 1709 
Morphine 1412 Morphine 1404 
Hydrocodone 1043 Hydrocodone 1037 
  Cholesterol 970 
Diphenhydramine 955 Diphenhydramine 944 
Alprazolam 886 Citalopram 879 
Citalopram 884 Alprazolam 876 
Diazepam 828 Diazepam 827 
Oxygen 814 Oxygen 814 
Nicotine 685 Nicotine 685 
Amitriptyline 623 Amitriptyline 622 
Acetaminophen 555 Acetaminophen 552 
Iron 533 Iron 533 
Hydromorphone 508 Hydromorphone 497 
Fentanyl 469 Fentanyl 468 
Table 3 - Overall frequency of death certificates retrieved by 
each type of terminology variant. 
Drug  
category 
Variant type 
 
Aggregated number of 
death certificates* 
Ingredient 
Drug Name 35,916 
36,007 
Total = 
37,215 
Synonyms 48 
Misspellings 398 
Precise 
Ingredient 
Drug Name 122 
122 Synonyms 0 
Misspellings 0 
Brand 
Name 
Drug Name 1,299 
1,323 Synonyms 1 
Misspellings 25 
* Some death certificates are counted multiple times here 
when more than one drug is mentioned. 
Table 4 - Top-5 brand names mentioned in death certificates. 
Brand 
name 
Generic  
name 
Number of death 
certificates retrieved 
Coumadin Warfarin 926 
Plavix Clopidogrel 57 
Tylenol Acetaminophen 35 
Adriamycin Doxorubicin 33 
Lovenox Enoxaparin 16 
Error Analysis 
The error analysis reveals the search terms that lead to loss in 
recall. Table 5 shows the top-10 drug entities which have the 
highest difference in retrieval performance. These drug entities 
explain 61.2% (1007/1645) of the loss in recall. Most of the 
search terms responsible for the loss in recall are abbreviations 
(e.g., ETOH for ethanol). This particular term is responsible for 
52.9% (870/1645) of the loss in recall. Adding this one term 
into ACL would decrease the loss in recall from 4.30% to 
1.97%. 
Upon inspection of the top-20 drug entities, we observed that 
some drug entities (from both ACL and MCL) tend to generate 
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false positive results, i.e., retrieve death certificates for which 
the drug mentioned is not the cause of death (e.g., Iron, 
mentioned in the context of ‘iron deficiency anemia’, not iron-
related overdose). Most of these drug entities have the semantic 
type of ‘T196 Element’ (e.g. iron, oxygen, gold, helium) and 
could easily be eliminated if it is confirmed that they yield false 
positives. 
Table 5 - Top-10 drug entities which have the highest difference in retrieval performance. The search terms are only present in MCL 
and responsible for the loss in recall. Only the most significant search terms are listed, along with their terminology variant types. 
Drug entity 
Number of death certificate 
retrieved Difference Search terms (Number of death certificates not retrieved with ACL query)  MCL ACL 
Ethanol 4561 3588 973 Abbreviation - ETOH (870) 
Cannabis Sativa Subsp. Indica Top 107 0 107 Synonym - Marijuana (29) 
1,1-difluoroethane 78 0 78 Abbreviation - Difluoroethane (51) 
Alteplase 37 5 32 Abbreviation - TPA (32) 
Dronabinol 31 3 28 Abbreviation - THC (5) 
Isopropyl Alcohol 33 7 26 Synonym - Isopropanol (10) 
Bupropion 271 248 23 Misspelling - Buproprion (1) 
Cyclobenzaprine 345 326 19 Misspelling - Cyclobenzapine (1) 
Methamphetamine 2964 2946 18 Abbreviation - Meth (7) 
Dextromethorphan 213 196 17 Misspelling - Nyquil (1) 
Sustainability 
RxNorm is updated monthly. Since ACL is built 
programmatically, it can be easily updated when new versions 
of RxNorm are released. Unlike MCL, the updated ACL will 
identify mentions of new drugs in death certificates. The 
algorithm used for generating misspellings is fast and could be 
run easily on new versions of RxNorm. 
Limitations 
Our study only focused on drug identification. Assessing 
whether drug mentions in death certificates actually correspond 
to drug-related deaths is beyond the scope of this investigation. 
Substances mentioned in death certificates are sometimes non- 
drugs (e.g., fumes, cigarette, asbestos) or drug class names 
(e.g., opiates, narcotics, antipsychotic, steroid) and are not 
covered by RxNorm. If ICD-10 is not sufficient for coding 
these substances, other sources can be investigated (e.g., drug 
classifications systems).  
In this preliminary retrieval study, we only included the 184 
misspellings that appear in our corpus of death certificates. 
Restricting misspellings to this small subset would not support 
the identification of different spelling variants in another corpus 
of death certificates. However, given the performance of the 
search engine, using the complete list of misspellings would not 
be a major issue. 
Conclusions 
In this study, we explored an automated approach to compiling 
a list of search terms for identifying drug mentions in death 
certificates. We showed that the automatically compiled list 
(ACL) has a competitive retrieval performance for individual 
drugs compared to the manually curated list (MCL), with only 
a slight loss in recall, and can reproduce similar drug overdose 
trend analysis results. Importantly, unlike the manual approach, 
our automated approach is dynamic, scalable and sustainable. 
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